A 58-year-old Indian male with hypertension and dyslipidemia presents with LDL cholesterol of 180 mg/dL despite dietary modification. The structure marked **B** in the cholesterol synthesis pathway diagram is the rate-limiting enzyme. Which of the following drugs acts on this enzyme to reduce LDL cholesterol and is most effective for cardiovascular mortality reduction in this patient?